Online inquiry

IVTScrip™ mRNA-Human ARPC5, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A))   (CAT#: GTTS-WK28671MR)

This product GTTS-WK28671MR is a type of mRNA having 30 nt poly(A) tail and modified with Cap 1 & 5-Methyl-CTP & Pseudo-UTP. It ecodes the ARPC5 protein. This product can be used in Meiotic prophase fetal germ cell-related researches.
Specifications
Product type mRNA
Modified bases 5-Methyl-CTP & Pseudo-UTP
5' Cap Cap 1
Species Human
RefSeq NM_001270439.2
Applications Gene therapy research
Format Powder
Quantity 100 µg
Purification Chromatography
Target Gene
Gene ID 10092
UniProt ID O15511
Download
Download resources about mRNA therapeutics development to boost your research.
CUSTOMER REVIEWS and Q&As

There are currently no Customer reviews or questions for IVTScrip™ mRNA-Human ARPC5, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) (GTTS-WK28671MR). Click the button above to contact us or submit your feedback about this product.
See other products
CAT Product Name Product Type CDs
GTTS-WK23778MR IVTScrip™ mRNA-Human ARGFX, (Cap 0, N1-Methylpseudo-UTP, 30 nt-poly(A)) mRNA ARGFX
GTTS-WK22035MR IVTScrip™ mRNA-Human ARL14, (Cap 0, N1-Methylpseudo-UTP, 120 nt-poly(A)) mRNA ARL14
GTTS-WK23504MR IVTScrip™ mRNA-Human ARHGDIA, (Cap 0, Pseudo-UTP, 30 nt-poly(A)) mRNA ARHGDIA
GTTS-WK9684MR IVTScrip™ mRNA-Human ABTB1, (Cap 0, 5-Methoxy-UTP, 30 nt-poly(A)) mRNA ABTB1
GTTS-WK25959MR IVTScrip™ mRNA-Human ARMCX2, (Cap 1, 5-Methoxy-UTP, 120 nt-poly(A)) mRNA ARMCX2
GTTS-WK22091MR IVTScrip™ mRNA-Human ASAP1, (Cap 0, N1-Methylpseudo-UTP, 120 nt-poly(A)) mRNA ASAP1
GTTS-WK27209MR IVTScrip™ mRNA-Human ASF1B, (Cap 1, Pseudo-UTP, 30 nt-poly(A)) mRNA ASF1B
GTTS-WK18567MR IVTScrip™ mRNA-Human ANXA8L1, (Cap 1, N1-Methylpseudo-UTP, 120 nt-poly(A)) mRNA ANXA8L1
All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
×

Webinar Register

Simone Pinto Carneiro, Ph.D.

Group Leader, Ludwig-Maximilians-University of Munich

date-time 10 AM EDT | May 19, 2026

Register Now →